Publication | Closed Access
Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia
26
Citations
33
References
2021
Year
The results from this study indicate the potential role of SLCO1B1 rs2306283 as a pharmacogenomic marker to guide and optimize methotrexate treatment for delayed elimination in children with acute lymphoblastic leukemia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1